Vasodilators Flashcards
why does increasing K+ channel opening relax vascular smooth muscle
K+ flux sets the membrane potential
the longer the K+ channels are open, the closer the membrane potential is to K+ equilibrium potential
the closer the membrane potential is to the K+ equilibrium potential, the harder it is to depolarize the membrane enough to open voltage gated Ca2+ channels
drugs that are K+ channel agonists/openers
Minoxidil
Diazoxide
Adenosine
minoxidil metabolism
prodrug
activated in vivo by sulfotransferase 1A1
what is minoxidil used with
with loop diuretics and beta blockers
effects of minoxidil
very potent vasodilator - effective in severe, drug resistant forms of htn
what may contribute to minoxidil efficacy
cAMP PDE inhibition
minoxidil structure
diazoxide indication
used IV to tx acute htn
effects of diazoxide
very potent vasodilator - effective in severe, drug resistant forms of htn
diazoxide moa
inhibits release of insulin from pancreatic beta cells
diazoxide structure
what does adenosine bind to
A1 receptor- a GPCR
what does adenosine do
increases conductance of a K+ channel
what is adenosine used for
supraventricular arrhythmias
coronary stress test
where is the nitric oxide synthase
vascular endothelium
where does NO diffuse to
vascular smooth muscle
what is found in vascular smooth muscle
guanylate cyclase
how can NO directly relax smooth muscle
by being exogenously applied
where does NO bind and then what does it do
NO binds to heme iron prosthetic group in guanylate cyclase, stimulating production of cGMP and activating protein kinase G (cGKI)
how does protein kinase G relax smooth muscle
inhibition of L-type Ca2+ channels (Cav1.2)
stimulation of Ca2+ activated K channels (BKca)
decreased MLC phosphorylation (myosin phosphatase 1)
enhanced Ca2+ uptake in to ER (phospholamban)
what are features of organic nitrates
non-selective vasodilators
breakdown to NO
don’t require functional endothelium
acute or chronic admin
types of organic nitrates/nitrites
organic nitrates PK
organic nitrates indications
given sublingually in tx of acute angina attacks
given orally or transdermally for prolonged prophylaxis
tolerance occurs with continuous admin
pharmacogenetics of glycerol trinitrate
glu 504 Lys polymorphism in ALDH-2
glu 504 is 10x more efficient in metabolizing GTN
what likely accounts for lack of efficacy of GTN in large % of asian pop
30-50% of asian pop has at least one Lys 504 allele
what is the diff in activation of GTN and ISMN/ISDN
ISMN and ISDN activation is ALDH-2 independent
what is the mechanism of cell damage initiated by hyperglycemia
AGE precursor methylglyoxal inhibits vasorelaxation stimulated by acetylcholine/NO
sodium nitroprusside (SNP) indication
given IV for acute management of hypertensive crisis and severe decompensated hf
SNP effects
dilates veins and arterioles
SNP metabolism
metabolized in erythrocytes to NO, 4CN-, and cyanmethemoglobin
hydralazine effects
dilates arterioles preferentially
hydralazine moa
moa not clear
appears to interfere with release of Ca from the ER
may also prevent oxidation of NO
what can hydralazine induce
Lupus-like syndrome
what does BiDil (the combo of hydralazine + ISDN) do
antioxidant activity potentiates vasodilatory activity of ISDN
BiDil decreases mortality in AA w CHF
what is the human type B natriuretic peptide (BNP) drug
natrecor (nesiritide)
natrecor indication
given IV in acutely decompensated HF
what does natrecor bind to and do
binds to and activates membrane bound guanylate cyclase in vascular smooth muscle and endothelial cells
where is natrecor metabolized
synthesized and secreted from heart muscle in response to increased blood volume
natriuretic peptide mechanism
neprilysin (a protease) inhibitor drug
sacubitril
what is sacubitril
a prodrug activated by esterases
sacubitril moa
prevents breakdown of BNP, enhancing its action (also angiotensin 2 and bradykinin)
what is sacubitril not used with
ACE inhibitors
sacubitril indication
tx hf
sacubitril combo product
ARNI - combination with ARB valsartan (entresto)
what drugs inhibit breakdown of cGMP/AMP
PDE
PDE3 inhibitor structures
what is the mechanism for controlling smooth muscle tone
what drug class is amrinone/milrinone
PDE3 (cAMP) inhibitor
amrinone/milrinone effect
direct positive inotropic effect on myocardium.
minimal chronotropic effect.
direct vasodilatory effect on vascular smooth muscle.
how is amrinone/milrinone given
IV
amrinone/milrinone indication
used mainly in ACUTE chf ONLY
what is sildenafil a potent and specific inhibitor of
cGMP PDE5
how selective is sildenafil for each PDE
10 fold more selective for PDE5 inhibition over PDE6 inhibition
4000 fold more selective for PDE5 inhibition over PDE3 inhibition
what can PDE6 inhibition lead to
bluish vision
what does sildenafil lack
systemic vasodilation
PDE5 inhibitor structures
all very similar
vardenafil has extra methyl group and nitrogen
levitra pk
shorter time to onset than viagra
more selective for PDE5 than viagra
cialis pk
more selective for pde5 than viagra
longer duration of action than viagra or levitra
why is PDE5 inhibitors CI w organic nitrates
both drugs increase accumulation of cGMP, leading to precipitous drop in BP
endothelial signaling
what are bosentan (tracleer) and macitentan (opsumit) used for
pulmonary arterial htn
tracleer and opsumit moa
endothelin receptor antagonists
block both ETa (VSM) and ETb (VSM + endothel) receptors
tracleer and opsumit MW
low
ambrisentan (letairis) moa
blocks only ETa receptors
what is letairis CI for
pregnancy
what sex are tracleer, opsumit, and letairis available for
female
PGI2, iloprost, selexipag effect
relax pulmonary vascular smooth muscle
PGI2, iloprost, selexipag indication
tx pulmonary arterial htn
PGI2 dosage form
IV
iloprost dosage form
inhalation
selexipag dosage form
oral
PGI2, iloprost, selexipag structures
riociguat (adempas) indication
tx pulmonary arterial htn
riociguat (adempas) moa
potentiates NO effect
stimulates sGC activity allosterically
increases cGMP conc in VSM
what is riociguat (adempas) not combined with
nitrates or PDE5 inhibitors
riociguat (adempas) CI
pregnancy
riociguat (adempas) risk
hemorrhage
what is riociguat (adempas) substrate for
P-gp, CYP1A1, CYP3A
what sex can take riociguat (adempas)
females only
why are PDE5 inhibitors indicated for PAH
PDE5 is expressed in vascular smooth muscle of lungs
both are thought to enhance vasodilatory effect of NO
which PDE5 inihibitors are indicated for PAH
sildanifil
cialis